EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies) , 2013. Scientific Opinion on the substantiation of a health claim related to Transitech ® and improvement of bowel function which is maintained after cessation of consumption of the food pursuant to Article 13(5) of Regulation (EC) No 1924/2006

EFSA Publication

Research output: Book/ReportReportCommissionedpeer-review

164 Downloads (Pure)

Abstract

Following an application from Vivatech, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Transitech® and improvement of bowel function which is maintained after cessation of consumption of the food. The food, Transitech®, that is the subject of the health claim is sufficiently characterised. The claimed effect, improvement of bowel function which is maintained after cessation of consumption of the food, is a beneficial physiological effect. In weighing the evidence, the Panel considered that the one study that investigated the claimed effect did not show an effect of Transitech® on bowel function which is maintained after cessation of consumption of the food. A cause and effect relationship has not been established between the consumption of Transitech® and improvement of bowel function which is maintained after cessation of consumption of the food.
© European Food Safety Authority, 2013
Original languageEnglish
Place of PublicationParma, Italy
PublisherEuropean Food Safety Authority
Number of pages11
DOIs
Publication statusPublished - 2013
SeriesEFSA Journal
Number6
Volume11
ISSN1830-5458

Keywords

  • Transitech
  • Bowel function
  • Maintenance
  • Health claims

Cite this